A window into new drug development for urologic oncology. Part II: Bench-to-bedside research improves survival in urologic cancer, and the discovery of better biomarkers can help predict patient response, toxicity, and resistance to therapy
| Image |  |
|---|---|
| Description | scientific article published on 26 March 2015 |
| Author/s |
author: Howard I. Scher |
| Publication date | March 26, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |